Annual report pursuant to Section 13 and 15(d)

4. Cash and Cash Equivalents

v3.8.0.1
4. Cash and Cash Equivalents
12 Months Ended
Mar. 31, 2018
Cash and Cash Equivalents [Abstract]  
Cash and Cash Equivalents
   

March 31,

2018

   

March 31,

2017 (Recast)

 
             
Securities purchased under reverse repurchase agreements   $ 26,320     $ 8,376  
Current accounts with brokers     22,749       259  
Current account with commercial banks     8,927       9,979  
Petty cash in bank vault and on hand     2,712       1,476  
Current account with Central Depository (Kazakhstan)     1,256       986  
Current account with National Settlement Depository (Russia)     1,242       696  
Current account with Central Bank (Russia)     980       645  
Accounts with stock exchange     214       8  
Current account in clearing organizations     131       191  
Total cash and cash equivalents   $ 64,531     $ 22,616  

 

As of March 31, 2018 and March 31, 2017, cash and cash equivalents were not insured. As of March 31, 2018 and March 31, 2017, the cash and cash equivalents balance included collateralized securities received under reverse repurchase agreements on the terms presented below:

 

    March 31, 2018  
    Interest rates and remaining contractual maturity of the agreements  
    Average Interest rate     Up to 30 days     30-90 days     Total  
Securities purchased under reverse repurchase agreements                        
Corporate equity     14.68 %   $ 10,026     $ 15,572     $ 25,598  
Corporate debt     14.96 %     521       201       722  
Total           $ 10,547     $ 15,773     $ 26,320  

 

    March 31, 2017 (Recast)  
    Interest rates and remaining contractual maturity of the agreements  
    Average Interest rate     Up to 30 days     30-90 days     Total  
Securities purchased under reverse repurchase agreements                        
Corporate equity     19.56 %   $ 8,346     $ 25     $ 8,371  
Corporate debt     24.00 %     5       -       5  
Total           $ 8,351     $ 25     $ 8,376  

 

The securities received by the Company as collateral under reverse repurchase agreements are liquid trading securities with market quotes and significant trading volume. The fair value of collateral received by the Company under reverse repurchase agreements as of March 31, 2018 and March 31, 2017, is $26,786 and $8,229, respectively. For additional information please see Note 12 Securities sold, not yet purchased – at fair value.